1.Moral Request of Giving Treatment to Serious burn Patients
Chinese Medical Ethics 1996;0(01):-
The treatment process of serious burn patients has the characteristics of overwork,dirt, weariness……. Patient has nocompany, can not take care oneself. In addition, patients andrelatives can not supervies treatment work. Therefore doctors and nurses should have high sense of responsibility, sympathetic heart. And also the paper advances the moral request in the course of treatment.
2.The effect of SiRNA -Oct4 expression on HCC cell line HepG2
Wenbo ZHOU ; Fangjun YUAN ; Can ZOU ; Zhengpeng ZHU ; Jianbo MA ; Zongqing DAI ; Youshun ZHANG
Chinese Journal of General Surgery 2011;26(6):467-469
Objective To investigate the expression of Oct4 in liver cancer, and the interrelation of the Oct4 and Wnt/β-catenin genes in hepatocellular carcinoma( HCC) cell line HepG2. Methods RTPCR technique was used to detect the expression of Oct4 and β-Catenin in HCC specimens; RNAi was used to knock-down the expression of Oct4 in HepG2, and the change of Wnt/β-catenin related genes were detected by Real time-PCR. Results In HCC specimens, the expression of Oct4 and β-Catenin in tumor and cirrhotic liver tissues were stronger than normal liver tissues. In SiRNA Oct4 HepG2 cells, the expression of Oct4 was downregulated, and β-catenin as well as Wnt10b were in a positive correlation with Oct4, TCF3 was in negative correlation with Oct4. Clone formation and move ability of the HepG2 were downregulated. Conclusions The expression of Oct4 was higher in tumor tissues than in normal liver tissues. Silencing Oct4 by SiRNA-0ct4 in HepG2 resulted in decreased ability of clone formation and cell movement.
3.The study on the Expression of Estrogen Receptors in Mast Cells of Bronchial Mucosa from Asthmatic Patients
Li CHEN ; Youyong TANG ; Wei LI ; Ming SHI ; Zhongwei YANG ; Zhengpeng ZHU ; Xiansheng LIU ; Chengguo WANG
Journal of Chinese Physician 2009;11(3):325-328
Objective To investigate the changes of estrogen receptor expression in mast cells of bronchial mucosa from female asthmatic patients.Methods 12 cases of female asthmatic patients and 9 cases of control female patients were enrolled in this study.The bronchial mucosa was obtained from the third grade bronchial by fiexible bronchofiberscope.Mast cells were marked by anti-mast cell tryptase monoclonal antibody,the expression of estrogen receptor(ER)were detected by anti-human estrogen receptor(ER)monoclonal antibodies.Results Mast cells and estrogen receptor positive cells of bronchial mucosa in female asthmatic patients were significantly higher than that in control group(P<0.01).Coincident with the known features of bronchial asthma,the cells positive for estrogen receptor were morphologically similar to the mast cells.The cells stained for estrogen receptors by dual immunostaining coincided exactly with cells labeled as mast cells.Conclusion The result suggested the estrogen may be involved in the pathogenesis of female asthmatic patient through the changes of estrogen receptor expression in mast cells of bronchial mucosa.
4.Efficacy of laparoscopic radical resection for rectal cancer in elderly patients with common chronic comorbidities
Yaoze LIANG ; Jiang YU ; Ce ZHANG ; Yanan WANG ; Yanfeng HU ; Li ZHEN ; Zhengpeng ZHU ; Guoxin LI
Chinese Journal of Digestive Surgery 2011;10(1):48-52
Objective To evaluate the feasibility, safety and clinical outcome of laparoscopic radical resection of rectal cancer in elderly patients with common chronic comorbidities. Methods The clinical data of 192 elderly patients with rectal cancer and common chronic comorbidities who were admitted to the Nanfang Hospital from January 2003 to December 2008 were retrospectively analyzed. All patients were divided into laparoscope group (n=91) and open group (n = 101). The operative procedures, clinicopathological data and outcomes of the two groups were collected and compared. All data were analyzed using the t test and chi-square test, and the survival of patients was analyzed using the life table and Kaplan-Meier curves. Results The sphincter preservation rate,operation time, postoperative length of hospital stay, morbidity rate were 85.7% (78/91), (194 ± 61) minutes,(14 ±8)days, 24.2% (22/91) in the laparoscope group, and they were 85.1% (86/101), (187 ±58) minutes,(14 ±8)days and 28.7% (29/101) in the open group, with no significant difference between the two groups (x2=0.012, t=0.874,-0.265, x2 =0. 505 , P > 0. 05) . The intraoperative blood loss was (108 ±78)ml in the laparoscope group, which was significantly less than (270 ± 600) ml in the open group (t =-2. 650, P <0.05). The time to first flatus, time to liquid diet, time to out-of-bed activity were (3 ± 1) days, (4 ± 2) days and (3 ± 1)days, which were significantly shorter than (4 ± 1)days, (5 ± 2)days and (5 ± 1)days in the open group,respectively (t =-4. 545,-4. 587,-13. 310, P < 0.05). The length of rectum resected and the number of lymph node dissected were (18 ± 5)cm and 9 ± 7 in the laparoscope group, and (18 ± 5)cm and 9 ± 8 in the open group, respectively, with no significant difference between the two groups (t = 1. 457, 0. 021, P > 0.05), while the distance of distal resection margin to the tumors was (3.8 ± 1.5) cm, which was significantly longer than (3.1 ± 1.5) cm of the open group (t = 0. 283, P < 0. 05). The 3-year cumulative survival rate, overall recurrence rate, local recurrence rate and distal metastasis rate in the laparoscope group were 76%, 12. 1% (11/91), 2.2% (2/91) and 9.9% (9/91), and they were 82%, 14.9% (15/101), 6.9% (7/101), 7.9% (8/101) in the open group, respectively, with no significant difference between the two groups (U=2. 600, x2 =0. 312, 2.400,0. 230, P > 0.05). There were no significant difference in the cumulative survival rate between patients in TNM stage Ⅰ, Ⅱ and Ⅲ in the two groups (P > 0.05). Conclusion Laparoscopic radical resection of rectal cancer is safe and feasible for elderly patients with common chronic comorbidities, and it has the advantages in quick recovery of patients after operaion.
5.Analysis of epidermal growth factor receptor gene mutations in patients with non-small cell lung cancer in Shiyan, Hubei
Huimin HUANG ; Zhengpeng ZHU ; Ying WEI
Cancer Research and Clinic 2022;34(12):921-924
Objective:To investigate the epidermal growth factor receptor (EGFR) gene mutation status in patients with non-small cell lung cancer (NSCLC) in Shiyan, Hubei and its relationship with the clinicopathological characteristics of patients.Methods:The data of 173 NSCLC patients who were admitted to Affiliated Dongfeng Hospital of Hubei University of Medicine from November 2017 to January 2020 were retrospectively analyzed. EGFR gene mutations in NSCLC tissues were detected by amplification refractory mutation system (ARMS)-TaqMan probe method, and clinicopathological data of patients were also collected to analyze the relationship between EGFR gene mutation status and clinicopathological characteristics of patients.Results:EGFR gene mutations were found in 76 of 173 patients, and the total mutation rate was 44.5%. The mutation rate of exon 18 was 6.6% (5/76), all of which were G719X mutation; the mutation rate of exon 19 was 46.1% (35/76), all of which were Del mutation; the mutation rate of exon 20 was 1.3% (1/76), which were EGFR gene 20ins mutation; the mutation rate of exon 21 was 44.7% (34/76), of which 33 cases were EGFR gene L858R mutation, and 1 case was EGFR gene L861Q mutation; 1 case was a double mutation of exon 19 Del combined with exon 20 T790M. The differences in EGFR mutation rates were statistically significant among patients with different gender, smoking history and pathological staging (all P < 0.05), and EGFR mutation rate in female patients was higher than that in male patients [59.7% (46/77) vs. 31.3% (30/96), χ2 = 14.08, P < 0.001], it was lower in patients with smoking history than that in patients without smoking history [27.1% (13/48) vs. 52.9% (63/119), χ2 = 9.22, P < 0.001], and it was higher in patients with adenocarcinoma than that in patients with non-adenocarcinoma [50.7% (75/148) vs. 4.0% (1/25), χ2 = 18.92, P < 0.001]. EGFR mutation status had no relevance with patients' age. Conclusions:The main types of EGFR mutations are exon 19 Del and exon 21 L858R in NSCLC patients in Shiyan, Hubei. EGFR mutations are more likely to occur in adenocarcinoma, female and no-smoking patients.
6.Exploring the Prevention and Treatment of Gastric Precancerous Lesions Based on the Four in One Diagnosis and Treatment Model of Disease Differentiation-Syndrome Differentiation-Symptom Differentiation-Constitution Differentiation
Zhengpeng WANG ; Weikai ZHU ; Jiarui LI ; Lu DAI ; Hui SHEN
Journal of Nanjing University of Traditional Chinese Medicine 2024;40(5):440-445
The idea of disease prevention runs through the traditional medical diagnosis and treatment system,and also plays an important role in the prevention and treatment of gastric precancerous lesions.This article organically combines disease differentiation,syndrome differentiation,symptom differentiation,and constitution differentiation to form a four in one diagnosis and treatment model.Disease differentiation means identifying the name of the disease and grasping the progression stage of the disease;syndrome differentiation means combining the macroscopic and microscopic aspects to accurately grasp the pathogenesis;symptom differentiation means identifying complications and clinical problems that need to be solved urgently;constitution differentiation means predicting syn-drome type bias and disease development.This model not only enables systematic diagnosis and treatment of gastric precancerous le-sions,but also provides targeted diagnosis and treatment plans for patients,with the characteristics of comprehensiveness,full process,and personalization.Therefore,combining the four in one diagnosis and treatment model of disease differentiation-syndrome differentia-tion-symptom differentiation-constitution identification with the disease prevention theory is conducive to the early detection of gastric precancerous lesions,timely tracking of the progress of the lesions,and the adoption of correct,comprehensive,and full-process inter-vention methods to reverse gastric precancerous lesions,which can play a positive role in the diagnosis,treatment,and prevention of gastric precancerous lesions.